Redcare Pharmacy Aktie
| 40,32EUR | -1,04EUR | -2,51% |
WKN DE: A2AR94 / ISIN: NL0012044747
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 1 569 | 1 847 | 2 075 | 2 266 | 2 649 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,68 | 0,65 | 0,87 | 1,05 | 1,11 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 433 | 344 | 500 | 500 | 619 |
| Summe Anlagevermögen | 360 | 398 | 549 | 528 | 627 |
| Summe Aktiva | 793 | 742 | 1 049 | 1 028 | 1 247 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 377 | 388 | 528 | 550 | 767 |
| Summe Eigenkapital | 415 | 355 | 520 | 478 | 479 |
| Summe Passiva | 793 | 742 | 1 049 | 1 028 | 1 247 |
Adresse
| Erik de Rodeweg 11/13, 5975 WD Sevenum | |
| Internet | http://www.redcare-pharmacy.com |
Management
|
Björn H. Söder
Chairman-Supervisory Board |
|
Dirk Brüse
Chief Commercial Officer |
|
Hendrik Krampe
Chief Financial Officer |
|
Jaska Marianne de Bakker
Vice Chairman-Supervisory Board |
|
Jérôme Cochet
Member-Supervisory Board |
|
Lode Fastré
Chief Information Officer |
|
Michael Köhler
Member-Supervisory Board |
|
Monica Ambrosi
Head-Investor Relations |
|
Olaf Heinrich
Chief Executive Officer |
|
Stephan Weber
Member-Supervisory Board |
|
Theresa Holler
Chief Operating Officer |